CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A

Journal of Leukocyte Biology

Volumn 78, Issue 1, 2005, Pages 144-157

  Mukherjee, Sambuddho ^a   Ahmed, Asma ^a   Nandi, Dipankar ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Costimulation; IL 10; IL 2 independent; Oxidative stress; T cell cycling and survival; TGF

Indexed keywords

B7 ANTIGEN; CASPASE; CD4 ANTIGEN; CD86 ANTIGEN; CONCANAVALIN A; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 2; LECTIN; NITRIC OXIDE; PROTEIN BCL X; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL PROCESSING; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; BCL-X PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CONCANAVALIN A; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN PEROXIDE; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NITRIC OXIDE; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 22144476493     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1104644     Document Type: Article

References (54)

1. Alegre, M-L., Frauwirth, K. A., Thompson, C. H. (2001) T cell regulation by CD28 ami CTLA4. Nat. Rev. Immunol. 1, 220-228.
2. Egen, J. G., Kulms, M. S., Allison, J. P. (2002) CTLA-4: new insights into its biological function and use in tumor immunnotherapy. Nat. Immunol. 3, 611-618.
3. Rudd, C. E., Schueider, H. (2003) Unifying concepts in CD28. ICOS and CTLA4 co-receptor signaling. Nat. Rev. Immunol. 3, 544-556.
4. Masteller, E. L., Chuang, E., Mullen, A. C., Reiner, S. L., Thompson. C. B. (2000) Structural analysis of CTLA4 function in vivo. J. Immunol. 164, 5319-5327.
5. Carreno, B. M., Bennetl, F., Chan, T. A., Ling, V., Luxenberg, D., Jussif, J., Baroja, M. L., Madrenas, J. (2000) CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J. Immunol. 165, 1352-1356.
6. Krunmel, M. F., Allison, J. P. (1996) CTLA-4 engagement inhabits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-2540.
7. Calvo, C. R., Amsen, D., Kruisbeek, A. M. (1997) Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphoryhition of T cell receptor ζ and ZAP70. J. Exp. Med. 186, 1645-1653.
8. Brunner, M. C., Chambers, C. A., Chan, F. K-M., Hanke, J., Winoto, A., Allison, J. P. (1999) CTLA4-mediated inhibition of early events of T cell proliferation. J. Immunol. 162, 5813-5820.
9. Krummel, M. F., Allison, J. P. (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-465.
10. Doyle, A. M., Mullen, A. C., Villarino, A. V., Hutchins, A. S., High, F. A., Lee, H. W., Thompson, C. B., Reiner, S. (2001) Induction of CTLA4 restricts clonal expansion of helper T cells. J. Exp. Med. 194, 893-902.
11. 1 induction. J. Immunol. 160, 12-15.
12. de Rocha Dias, S., Rudd, C. E. (2001) CTLA-4 blockade of antigen-induced cell death. Blood 97, 1134-1137.
13. + T lymphocytes in enhancing cell cycle progression and survival after activation with PMA and ionomyein. J. ionomycin. J. Leukoc. Biol. 72, 921-931.
14. Pandiyan, P., Gärtner, D., Soezeri, O., Radbruch, A., Schulze-Osthoff, K., Brunner-Weinzierl, M. C. (2004) CD152 (CTLA4) determines the unequal resistance of Th1 and Th2 cells against activation induced cell death by a mechanism requiring PI3 kinase function. J. Exp. Med. 199, 831-842.
15. Gribben, J. G., Freeman, G. J., Boussiotis, V. A., Rennert, P., Jellis, C. L., Greenfield, E., Barber, M., Restivo Jr., V. A., Ke. X., Gray, C. S., et al. (1995) CTLA4 mediates antigen-specific apoplosis of human T cells. Proc. Natl Acad. Sci. USA 92, 811-815.
16. + T lymphocytes induced by CTLA-4 crosslinking. Proc. Natl. Acad. Sci. USA 95, 10083-10088.
17. -/- mice display T cell-apoplosis resistance resembling that ascribed lu autoimmune-prone non-obese diabetic (NOD) mice. J. Autoimmun. 16, 105-113.
18. Perez, V. I., Van Parijs, L., Biuckians, A., Zheng, X. X., Strom, T. B., Abbas, A. K. (1997) Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411-417.
19. Walunas, T. L., Bluestone, J. A. (1998) CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J. Immunol. 160, 3855-3860.
20. Greenuwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K., Sharpe, A. H. (2001) CTLA-4 regulates induction of anergy in vivo. Immunity 14, 145-155.
21. Frauwirth, K. A., Alegre, M-L., Thompson, C. B. (2000) Induction of T cell amergy in the absence of CTLA-4/B7 interaction. J. Immunol. 164, 2987-2993.
22. + T cell anergy in vivo. J. Immunol. 167, 4936-4941.
23. + T cells. J. Exp. Med. 188, 1849-1857.
24. + T cells toward the Th1 subset by CTLA-4 costimulation. J. Immunol. 164, 3554-3562.
25. Sullivan, T. J., Letterio, J. J., van Elsas, A., Mamura, M., van Amelsfort, J., Sharpe, S., Mctzler, B., Chambers, C. A., Allison, J. P. (2001) Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation. Proc. Natl. Acad. Sci. USA 98, 2587-2592.
26. Höllsberg, P., Scholz, C., Anderson, D. E., Greenfield, E. A., Kuchroo, V. K., Freeman. C. J., Hafler, D. A. (1997) Expression of a hypoglycosylated form of CD86 (B7.2) on human T cells with altered binding properties to CD28 and CTLA4. J. Immunol. 159, 4799-4805.
27. Greenfield, E. A., Howard, E., Paradis, T., Nguyen, K., Benazzo, F., McLean, P., Hollsberg, P., Davis, C., Hafler, D. A., Sharpe, A. H., Freeman, G. J., Kuehroo, V. K. (1997) B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding. J. Immunol. 158, 2025-2034.
28. Schweitzer, A. N., Sharpe, A. H. (1999) Mutual regulation between B7-1 (CD80) expressed on T cells and IL-4. J. Immunol. 163, 4819-4825.
29. Taylor, P. A., Lees, C. J., Fiiurnier, S., Allison, J. P., Sharpe, A. H., Blazar, B. R. (2004) B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J. Immunol. 172, 34-39.
30. Wu, Y., Guo, Y., Huang, A., Zheng, P., Liu, Y. (1997) CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J. Exp. Med. 185, 1327-1335.
31. Zheng, P., Yan, W., Yong, G., Lee, C., Liu, Y. (1998) B7-CTLA4 interaction enhances both production of anti-tumor cytotoxic T lymphocytes and resistance to tumor challenge. Proc. Natl. Acad. Sci. USA 95, 6284-6289.
32. Anderson, D. E., Bieganowska, K. D., Bar-Or, A., Oliveira, K. M. L., Carreno, B., Collins, M., Hafler, D. A. (2000) Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population. Nat. Med. 6, 211-214.
33. + T cells. Proc, Natl. Acad. Sci. USA 97, 12711-12716.
34. Madrenas, J., Chan, L. A., Teft, W. A., Wu, P. W., Jussif, J., Kasaian, M., Carreno, B. M., Ling, V. (2004) Conversion of CTLA4 from inhihitor to activator of T cells with a bispeeific tandem single chain Fv ligand. J. Immunol. 172, 5948-5956.
35. Ahmann, C. B., Sachs, D. H., Hodes, R. J. (1978) Requirement for an la-bearing accessory cell in Con A-induced T cell proliferation. J. Immunol. 121, 1981-1989.
36. Quintans, J., Yokoyama, A., Evavold, B., Hirsch, R., Mayforth, R. D. (1989) Direct activation of murine resting T cells by con A or anti-CD3 Ig. J. Mol. Cell. Immunol. 4, 225-235.
37. Perrin, P. J., Davis, T. A., Sinool, D. S., Abe. R., June, C. H., Lee, K. P. (1997) Mitogenic stimulation of T cells reveals differing contributions for B7-1 and B7-2 costimulation. Immunology 90, 534-542.
38. Nagase, F., Abo, T., Hiramatsu, K., Suzuki, S., Du, J., Nakashima, I. (1998) Induction of apoptosis and tyrosine phosphorylation of cellular protcins in T cells and non-T cells by stimulation with concanavalin A. Microbiol. Immunol. 42, 567-574.
39. Pani, G., Colavitti, R., Borrello, S., Galeotti, T. (2000) Endogenous oxygen radicals modulate protein tyrosine phosphorylation and JNK-1 activation in lectin-stimulated thymocytes. Biochem. J. 347, 173-181.
40. Pongracz, J., Parnell, S., Anderson, G., Jaffrézou, J-P., Jenkinson, E. (2003) Con A activates an Akt/PKB dependent survival mechanism to modulate TCR induced cell death in double positive thymocytes. Mol. Immunol. 39, 1013-1023.
41. Lane, P., Gerhard, W., Huhele, S., Lanzavecchia, A., McConnell, F. (1993) Expression and functional properties of mouse B7/BBI using a fusion protein between mouse CTLA4 and human γ1. Immunology 80, 56-61.
42. Hildeman, D. A., Mitchell, T., Kuppler, J., Marrack. P. (2003) T cell apoptosis and reactive oxygen species. J. Clin. Invest. 111, 575-581.
43. Jaattela, M., Tschopp, J. (2003) Caspase-independent cell death in T lymphocytes. Nat. Immunul. 4, 416-423.
44. L. Immunity 3, 87-98.
45. Demetriou, M., Binkert, C., Sukhu, B., Tenenbaum, H. C., Dennis, J. W. (1996) Fetuin/α2-HS glyeoprotein is a transforming growth factor-β type II receptor mimic and cytokine antagonist. J. Biol. Chem. 271, 12755-12761.
46. Yu, X-Z., Martin, P. J., Anasetti, C. (2003) CD28 signal enhances apoptosis of CD8 T cells after strong TCR ligalion. J. Immunol. 170, 3002-3006.
47. + T lymphocytes from interleukin 2-deficient mice by costimulatory B7 molecules. Proc. Natl. Acad. Sci. USA 93, 2903-2908.
48. Appleman, L. J., Berezovskaya, A., Grass. I., Boussiotis, V. A. (2000) CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol. 164, 144-151.
49. Tivol, E. A., Boriello, F., Schweitzer, A. N., Lynch, N. P. Bluestone, J. A., Sharpe, A. H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
50. Jovasevie, V. M., Corelik, L., Bluestone, J. A. Mokyr, M. B. (2004) Importance of 1L-10 for CTLA4-medialed inhibition of tumor-eradicating immunity. J. Immunol. 172, 1449-1454.
51. + T cells exhibit distinct expression patterns of cytokines and cell surface molecules on their primary responses to varying doses of antigen. J. Immunol. 168, 3242-3250.
52. Egen, J. C., Allison, J. P. (2002) Cytoloxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16, 23-35.
53. Watanabe, Y., Morita, M., Akaike, T. (1996) Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 24, 702-710.
54. + T cells. J. Immunol. 168, 3825-3832.